PMGC HOLDINGS INC. Increase (Decrease) in Prepaid Expense and Other Assets
PMGC HOLDINGS INC. (ELAB) reported Increase (Decrease) in Prepaid Expense and Other Assets of $37.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$4.30K.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $41.30K.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $193.57K, a 11.46% decline year-over-year.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$73.88K.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.31K.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$65.10K, a 107.17% decline from fiscal 2023.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $907.34K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $37.00K 10-Q · filed 2026-08-14 | $230.57K derived: sum of 3 quarters · filed 2026-08-14 | $156.69K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $41.30K 10-Q · filed 2026-05-15 | $234.87K derived: sum of 2 quarters · filed 2026-05-15 | $160.98K derived: sum of 3 quarters · filed 2026-05-15 | $109.56K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $193.57K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $119.69K derived: sum of 2 quarters · filed 2026-03-30 | $68.26K derived: sum of 3 quarters · filed 2026-08-14 | -$1.31K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$73.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$125.31K derived: sum of 2 quarters · filed 2026-08-14 | -$194.88K 10-Q · filed 2025-11-14 | $23.74K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$51.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$121.00K 10-Q · filed 2026-08-14 | $97.63K derived: sum of 3 quarters · filed 2026-08-14 | -$48.80K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$69.58K 10-Q · filed 2026-05-15 | $149.05K derived: sum of 2 quarters · filed 2026-05-15 | $2.62K derived: sum of 3 quarters · filed 2026-05-15 | -$271.62K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $218.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $72.20K derived: sum of 2 quarters · filed 2026-03-30 | -$202.05K derived: sum of 3 quarters · filed 2026-03-30 | -$65.10K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$146.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$420.67K derived: sum of 2 quarters · filed 2025-11-14 | -$283.72K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$274.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$137.29K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $136.95K 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $907.34K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |